A systematic review and meta-analysis by Yang et al. evaluated the predictive value of PD-L1 in patients with HCC treated with ICIs, and it found that patients with a positive PD-L1 expression had better ORR (pooled odds ratio, 1.86, 95% CI, 1.35–2.55). Here, CD274 is linked to hepatocellular carcinoma.